You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 3, January 16, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Colon Cancer
 •Quality of Life
 •Surgery
 •Surgical Interventions
 •Colorectal Surgery
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Trials Are Mandatory for Improving Surgical Cancer Care

Nicholas J. Petrelli, MD

JAMA. 2002;287:377-378.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of THE JOURNAL, Weeks and colleagues for the Clinical Outcomes of Surgical Therapy (COST) Study Group1 present the results of a multicenter randomized trial comparing quality-of-life (QOL) outcomes for patients with colon cancer who had open colectomy vs laparoscopic-assisted colectomy (LAC). While the findings that LAC provided only modest advantages compared with open colectomy are important for surgeons treating patients with colon cancer, the study also emphasizes the need for high-quality, rigorous randomized trials for improving surgical cancer care and underscores the importance of physicians to increase their efforts to enroll patients in such studies.

The COST study was designed to compare the safety, efficacy, QOL outcomes, and cost of LAC vs standard open colectomy in patients with primary colon adenocarcinoma. The primary objective of the COST study is to determine whether disease-free survival and overall survival following LAC and open colectomy are . . . [Full Text of this Article]

Author Affiliation: Helen F. Graham Cancer Center, Christiana Care, Newark, Del.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Short-term Quality-of-Life Outcomes Following Laparoscopic-Assisted Colectomy vs Open Colectomy for Colon Cancer: A Randomized Trial
, , , , , and
JAMA. ;287():321-328.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.